SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Micromet Inc (MITI)
An SI Board Since February 2006
Posts SubjectMarks Bans Symbol
196 15 0 MITI
Emcee:  dr.praveen Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
71Micromet Up On Positive Dendreon Immunotherapeutic Data Last update: 4/14/2009 3Saulamanca-4/14/2009
70Appears that MITI is reacting positively to the DNDN news today...stock is up 16Arthur Radley-4/14/2009
69BETHESDA, Md., April 8 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI - Arthur Radley-4/8/2009
68finance.yahoo.com Milestone payment and start of trial in Europe..Arthur Radley-4/2/2009
67Merriman Curran Ford issued BUY report this morning...stock has clinked up back Arthur Radley-3/25/2009
66News Story Micromet Started At Buy By Piper Jaffray >MITI 1:02 PM EDT MarcArthur Radley-3/23/2009
65BETHESDA, Md., March 23 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI -Arthur Radley-3/23/2009
64Practically speaking you have to compare those SAE's and outcomes with the aBiomaven-3/13/2009
63MITI URL correction: MITI had disclosed the following AE's (where 1 pt had ejgopher-3/13/2009
62MEDI has been trying to recruit 45 pts since June 2004 for the P1 Blinatumomab (ejgopher-3/13/2009
61The replacement candidate is a new BiTE antibody that the companies will developrkrw-3/13/2009
60>>MEDI dumped blinatumomab (MT103/MEDI-538) due to SAE’s Where did you heBiomaven-3/13/2009
59MEDI dumped blinatumomab (MT103/MEDI-538) due to SAE’sejgopher-3/12/2009
58pharmaweblog.com Don't know anything about this blogger(Fred Cohen, MD), buArthur Radley-2/19/2009
57Micromet Inc. at Biotechnology Industry Organization BIO CEO & Investor CoSaulamanca-2/10/2009
56Sounds like it just means Bayer has an interest in a BiTE antibody and gets a yeSaulamanca-1/12/2009
55<i>Under the terms of the agreement, Bayer Schering Pharma will pay MicromSteve Lokness-1/12/2009
54Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer ScheringSaulamanca-1/12/2009
53August 15, 2008 Antibody Drug Unleashes Tumor-Killer T Cells Trial of a two-pronSaulamanca-8/17/2008
52Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Saulamanca-8/17/2008
51They presented a "Retrospective Analysis" of the results of the PII ofJibacoa-6/5/2007
50>>Micromet and Nycomed Enter Into Exclusive Worldwide Collaboration to Devtuck-5/24/2007
49Micromet and MedImmune Present Data From Preclinical Study of New BiTE(R) MolecuSaulamanca-4/18/2007
48Micromet, Inc. receives $10 million milestone payment from Serono for completionnigel bates-12/4/2006
47Micromet Presents New Anti-IL-2 Antibody with Unique Mode of Action Wednesday Ocnigel bates-10/25/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News